Market Tracker

03/04 3:18pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

18.59
Delayed Data
As of 3:02pm ET
 +0.30 / +1.64%
Today’s Change
5.40
Today|||52-Week Range
25.60
+15.90%
Year-to-Date

Today’s Trading

Previous close18.29
Today’s open18.13
Day’s range17.56 - 18.86
Volume274,396
Average volume (3 months)702,403
Market cap$924.0M
Dividend yield--
Data as of 3:02pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+19.68%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book6.78

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+0.73+3.99%
OMEROmeros Corp+1.11+4.44%
OREXOrexigen Therapeutic...+0.93+12.17%
KPTIKaryopharm Therapeut...+0.18+0.66%
Data as of 3:18pm ET, 03/04/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts